The IVF Journey, Stage by Stage
A plain-language, stage-by-stage guide to what happens during IVF treatment — from the first consultation through early pregnancy follow-up — built from the same clinic-approved Q&A content that powers My Bloom Aura's patient triage engine.
This guide is educational and does not replace advice from your own clinical team. Always follow the specific instructions given by your treating clinician, as protocols vary between clinics and individual patients.
Pre-Consultation
Patient-centred groundwork before your first IVF consultation — cycle timing, required tests, lifestyle preparation, and what to expect.
IVF is recommended for patients with tubal factor infertility, low-quality eggs or sperm, or recurrent miscarriage. IUI is simpler and usually used for mild fertility issues.
Usually, a complete cycle or at least one month prior is recommended to regulate your cycle and prepare the ovaries.
Tests include FSH, LH, AMH, estradiol, TSH, progesterone, and CBC to evaluate ovarian function and hormonal status.
Yes, transvaginal ultrasound is performed to assess follicle size and count, endometrial thickness, and uterine structure.
A balanced diet rich in protein, vegetables, and fruits with low sugar and fat is recommended. Folic acid and vitamin D supplementation is advised.
Any hormonal, fertility-related, or herbal supplements should be reported as they may interfere with ovarian stimulation.
A BMI of 18.5–25 is optimal. BMI outside this range can reduce ovarian response and pregnancy success.
Yes, smoking and alcohol reduce egg and sperm quality. Caffeine should be limited (<200mg/day).
High stress and poor sleep can disrupt hormonal balance and affect egg quality. Psychological support is recommended if needed.
Light to moderate exercise is allowed; heavy or competitive exercise may affect ovarian response.
Vaccinations against rubella, hepatitis B, and COVID-19 are recommended before treatment.
Yes, these conditions should be well-controlled to optimize ovarian response and pregnancy outcomes.
He should provide medical history, sperm analysis, and any chronic health conditions relevant to fertility.
Yes, previous pregnancy outcomes may indicate the need for genetic or hormonal evaluation before starting IVF.
In cases of recurrent miscarriage or family history of genetic disorders, preconception carrier screening is recommended.
Through AMH levels, antral follicle count (AFC), and considering patient age to estimate egg quantity and quality.
Risks include OHSS (Ovarian Hyperstimulation Syndrome), allergic reactions, and over-response; monitoring is required.
In cases of recurrent miscarriage or IVF failure, antibody and immunologic factor testing can be useful.
Yes, prior hormonal therapy or contraception may affect cycle timing and ovarian response.
TSH should be optimized (0.5–2.5 mIU/L) to maximize chances of pregnancy.
Yes, these may require medical or surgical intervention prior to starting IVF.
Generally no, unless medically indicated or advised by the physician.
Maintain personal hygiene, healthy weight, stress management, and lifestyle optimization before treatment.
Review of medical history, lab results, discussion of IVF plan, timeline, risks, and answers to patient questions.
Once the physician reviews your labs, ultrasound, and history and confirms no contraindications, the IVF cycle can be scheduled.
Ovarian Stimulation
An evidence-based clinical guide to the medications, monitoring, and safety checks used during ovarian stimulation.
FSH and hMG are used to stimulate the ovaries by mimicking natural pituitary FSH. This allows multiple follicles to develop instead of a single dominant follicle, increasing the number of retrievable oocytes.
They are given as daily subcutaneous injections to maintain stable hormone levels and controlled follicular growth. Precise timing is essential for synchronized ovarian response.
They override the natural ovulation cycle to recruit multiple follicles, which is essential for controlled oocyte retrieval and embryo generation.
Baseline FSH, LH, AMH, Estradiol, TSH, progesterone, and CBC are used to assess ovarian reserve, endocrine status, and treatment safety.
AMH reflects ovarian reserve and predicts the expected ovarian response to stimulation, guiding individualized drug dosing.
Transvaginal ultrasound evaluates antral follicle count and monitors follicular growth to ensure appropriate response to therapy.
Estradiol is produced by developing follicles. Rising levels indicate response, while excessive elevation may signal risk of OHSS.
Ovarian Hyperstimulation Syndrome is an exaggerated response to fertility drugs, driven by high vascular endothelial growth factor (VEGF) activity leading to fluid shifts.
Rapid abdominal distension, severe pain, nausea, vomiting, shortness of breath, and sudden weight gain require urgent evaluation.
Dose individualization, GnRH antagonist protocols, and close estradiol and ultrasound monitoring reduce risk significantly.
Yes. Smoking, alcohol, poor sleep, and chronic stress can negatively affect hormonal regulation and oocyte quality.
Light activity is safe, but high-impact exercise is avoided due to ovarian enlargement and torsion risk.
BMI affects hormone metabolism and ovarian sensitivity to gonadotropins, influencing response variability.
Yes. Thyroid imbalance disrupts follicular development; optimal TSH is generally 0.5–2.5 mIU/L.
Hormonal medications, anticoagulants, and some herbal supplements may alter ovarian response and should be disclosed.
LH supports theca cell function, enabling androgen production which is essential for estrogen synthesis and follicle maturation.
Through AMH, AFC (antral follicle count), and age, which together estimate ovarian quantity and expected response.
Protocols are individualized based on ovarian reserve, age, prior response, and OHSS risk profile.
It prevents premature LH surge and spontaneous ovulation before planned oocyte retrieval.
Ovarian response is dynamic, requiring dose adjustments to optimize safety and follicular development.
Yes. Prior response patterns guide protocol selection and dosing adjustments.
To identify inherited disease risk in couples with recurrent miscarriage or known genetic conditions.
Chronic stress may affect the hypothalamic–pituitary–ovarian axis and indirectly influence outcomes.
A balanced diet supports metabolic stability, though no strict IVF-specific diet is universally required.
Usually allowed unless ovarian enlargement increases torsion risk or physician advises otherwise.
Mature follicles (typically 17–20 mm) indicate optimal timing for final oocyte maturation trigger.
hCG or GnRH agonist is used to induce final oocyte maturation before retrieval.
It increases vascular permeability, raising risk of OHSS and systemic fluid imbalance.
Counseling and stress management improve adherence and may positively influence physiological response.
Short travel is acceptable, but long-distance travel is discouraged due to monitoring needs.
Pre Egg Retrieval
What to expect in the days before egg retrieval, including trigger injection timing and OHSS awareness.
Ovarian stimulation causes multiple follicles to grow, enlarging the ovaries and leading to temporary fluid retention and bloating.
Mild bloating is normal; severe symptoms may indicate OHSS and require medical attention.
This is due to fluid retention from high estrogen levels, not fat gain.
Enlarged ovaries with multiple follicles create pressure and discomfort.
Hormonal fluctuations and high estrogen levels affect mood and energy.
They stimulate multiple follicles to grow instead of a single egg.
A hormone injection that induces final maturation of eggs before retrieval.
Eggs have a narrow maturation window; incorrect timing affects egg quality.
It is given as a subcutaneous or intramuscular injection depending on protocol.
Usually in the lower abdomen or outer thigh.
It mimics LH surge and initiates final oocyte maturation.
Eggs may ovulate before retrieval and be lost.
Eggs may remain immature and unusable.
To assess estradiol levels and evaluate OHSS risk.
It reflects the number and activity of growing follicles.
To monitor follicle size and maturation.
Usually 17–22 mm indicates maturity.
Risk of OHSS increases; sometimes embryo freezing is recommended.
Ovarian hyperstimulation syndrome, an excessive response to fertility medication.
Severe pain, rapid weight gain, vomiting, or shortness of breath.
Patients with PCOS, high AMH, or strong ovarian response.
Because sedation anesthesia is used during the procedure.
It is a minimally invasive ultrasound-guided procedure.
No, sedation prevents pain during the procedure.
Usually 10–20 minutes.
A needle collects eggs from ovarian follicles under ultrasound guidance.
They are sent to the embryology lab for evaluation.
They are checked for maturity and quality.
Only light activity is allowed.
Generally avoided due to enlarged ovaries and torsion risk.
Short travel is possible but not recommended.
All embryos are frozen instead of fresh transfer for safety.
To prevent OHSS or due to poor ovarian response.
It helps reduce OHSS risk and supports circulation.
To safely retrieve the maximum number of mature eggs.
Eggs complete final maturation before retrieval in 34–36 hours.
In some stimulation protocols, progesterone is introduced to support endometrial preparation and cycle regulation depending on clinician strategy.
After Egg Retrieval
Fertilisation and embryology — what happens to your eggs after retrieval, IVF vs. ICSI, and embryo development.
Ovarian enlargement and residual hormonal stimulation cause temporary fluid retention and abdominal bloating, which gradually resolves.
Because the ovaries may not produce sufficient luteal progesterone after stimulation, supplementation supports implantation.
It stabilizes and prepares the endometrium for embryo implantation.
Combination of anesthesia effects, hormonal changes, and ovarian response.
Yes, mild cramping is expected due to ovarian puncture and enlargement.
Yes, to monitor hormonal status and assess risk of ovarian hyperstimulation syndrome (OHSS).
To check ovarian size and detect fluid accumulation indicating OHSS risk.
They are transferred to the embryology lab for evaluation and fertilization.
They are assessed for maturity (MII stage) to determine fertilization potential.
IVF allows sperm to fertilize naturally in the lab; ICSI injects a single sperm directly into the egg.
In cases of male factor infertility or previous fertilization failure.
Some eggs are immature or have cytoplasmic or genetic limitations.
The single-cell result after sperm and egg fusion, marking the start of embryo development.
To allow embryos to develop and self-select for viability.
A Day 5 embryo with inner cell mass and fluid cavity, optimal for implantation.
It has higher implantation potential and better selection of viable embryos.
To preserve quality and allow transfer in a safer uterine environment.
A scoring system used to evaluate embryo quality based on morphology and development.
Due to genetic abnormalities or cellular division failure.
No, only a subset have the genetic and metabolic quality to progress.
Embryos are highly sensitive to temperature, pH, and culture conditions.
Endometrial receptivity and embryo developmental stage.
To support implantation and early pregnancy development.
All embryos are frozen instead of fresh transfer to improve safety or outcomes.
If hormonal or uterine conditions are not optimal.
They manage fertilization, culture, and selection of embryos.
Due to genetic diversity and differences in gamete quality.
The process where the embryo attaches to the uterine lining.
Because success depends on embryo quality, uterine receptivity, and genetic factors.
It may be due to poor egg or sperm quality or fertilization failure.
Eggs and embryos have narrow biological windows for optimal success.
Severe stress may affect hormonal balance but is not the primary determinant.
To create viable embryos for safe transfer and pregnancy establishment.
To optimize uterine conditions and reduce complications like OHSS.
Embryo transfer and pregnancy testing (beta-hCG confirmation).
Embryo Transfer
Embryo transfer and the early days afterward, including progesterone support and the beta-hCG pregnancy test.
Embryo transfer is a simple procedure where a selected embryo is placed into the uterine cavity using a thin catheter.
No, it is usually performed without anesthesia and is generally painless, though mild discomfort may occur.
A moderately full bladder is often required and prescribed medications should be continued as instructed.
The procedure usually takes 5 to 10 minutes and is performed in an outpatient setting.
No, most patients feel only mild pressure or discomfort.
It improves ultrasound visualization of the uterus and helps guide accurate embryo placement.
A soft catheter is used to gently deposit the embryo into the uterine cavity under ultrasound guidance.
Yes, ultrasound guidance helps ensure accurate placement of the embryo.
The embryo remains in the uterus and begins the process of implantation if conditions are favorable.
Progesterone supports the uterine lining and is essential for implantation and early pregnancy maintenance.
It stabilizes the endometrium and makes it receptive to embryo implantation.
Yes, in some protocols estrogen is added to support endometrial thickness.
Missing doses may reduce implantation success and increase risk of treatment failure.
No, prolonged bed rest is not recommended and does not improve pregnancy outcomes.
Yes, normal light walking and daily activities are allowed.
No, light activity is encouraged; strict bed rest is unnecessary.
Avoid heavy lifting, intense exercise, and high-impact physical activity.
Yes, mild cramping or discomfort is common and usually temporary.
Yes, light spotting may occur and can be related to implantation.
Hormonal medications such as progesterone can cause bloating.
Yes, absence of symptoms does not indicate failure.
Implantation is the process where the embryo attaches to the uterine lining.
It usually occurs 1 to 5 days after embryo transfer depending on embryo stage.
It is a short period when the endometrium is receptive to embryo attachment.
Reasons include embryo quality, uterine receptivity, or genetic abnormalities.
Embryo quality and endometrial receptivity are the key factors.
Beta hCG is a blood hormone used to confirm pregnancy after embryo transfer.
It is usually measured 10 to 14 days after embryo transfer.
To confirm that levels are rising appropriately, indicating a healthy pregnancy.
It indicates early pregnancy, but must be confirmed with rising levels.
Testing too early may show inaccurate or false-negative results.
Success depends on embryo quality, uterine conditions, and biological variability.
Maintain a balanced diet, avoid stress, and continue medications as prescribed.
Severe stress may have indirect effects, but it is not the primary determinant.
To achieve successful implantation and establish a healthy pregnancy.
Pregnancy Follow-up
Early pregnancy monitoring after a positive test — hormone tracking, ultrasound milestones, and what's normal.
It is the early pregnancy follow-up phase after embryo transfer, including hormone monitoring, ultrasound, and pregnancy confirmation.
A hormone produced by the embryo that confirms pregnancy and reflects early development.
Usually 10–14 days after embryo transfer.
To ensure it is rising appropriately, indicating a healthy pregnancy progression.
It suggests normal early embryonic development and viable pregnancy progression.
It may indicate late implantation, biochemical pregnancy, or non-viable pregnancy.
Medication continues and early ultrasound is scheduled for pregnancy confirmation.
Usually at 5–6 weeks of gestation.
A gestational sac inside the uterus.
Typically at 6–7 weeks of pregnancy.
To confirm intrauterine pregnancy and assess early development.
Because the placenta is not yet fully developed and hormonal support is required.
Usually until 10–12 weeks of pregnancy.
It may increase risk of miscarriage in early pregnancy.
In some IVF protocols, estrogen support may continue in early weeks.
Light spotting can occur but should always be evaluated.
Fatigue, nausea, breast tenderness, and mild cramping can be normal.
Yes, absence of symptoms does not mean pregnancy failure.
Due to rising progesterone and metabolic changes.
Due to increasing hCG levels.
Light bleeding caused by embryo attachment to the uterine lining.
It refers to pregnancy loss, most commonly due to chromosomal abnormalities.
In the first trimester, especially before heartbeat detection.
Not inherently; maternal age is the strongest factor.
Often due to genetic or chromosomal abnormalities.
A very early pregnancy loss detected only by beta hCG.
Short travel is usually allowed if pregnancy is stable.
Light activity like walking is recommended; avoid intense exercise.
Usually allowed unless advised otherwise by the doctor.
Balanced diet with adequate protein, hydration, and prenatal vitamins.
Severe stress may have indirect effects but is not the primary determinant.
Usually after 10–12 weeks when pregnancy is stable.
To confirm a healthy ongoing pregnancy and transition to routine prenatal care.
Risk of miscarriage significantly decreases and care shifts to routine obstetric follow-up.
Bringing This Level of Care to Your Clinic
My Bloom Aura uses clinic-approved Q&A content like this, matched to each patient's stage in their journey, to answer routine questions instantly and escalate anything clinically significant to your team.
This IVF Patient Guide is published by My Bloom Aura, an AI Patient Reception and Coordination System for women's health and fertility clinics in the UK, engineered by VisionXY7. The guide is for general patient education and does not replace individualised clinical advice from a treating fertility specialist.